Evidence map›Paper›PMID 33713848›Full record

ArticleBone2021

The TrkA agonist gambogic amide augments skeletal adaptation to mechanical loading.

Gabriella Fioravanti, Phuong Q Hua, Ryan E Tomlinson

Open access · greenAbstract read
In one paragraph

Article in Bone, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Methodological aspects ofJournal of musculoskeletal & neuronal interactions · 2023
    Pooled it
  2. Boosting Sensory Nerve-to-Bone Interactions Enhances Hedgehog Mediated Calvarial Bone Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Review
  5. Small-Molecule Trk Agonists: Where Do We Go from Here?Journal of medicinal chemistry · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gabriella FioravantiDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, United States of America.
Phuong Q HuaDepartment of Biomedical Engineering, Drexel University, Philadelphia, PA, United States of America.
Ryan E TomlinsonDepartment of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, United States of America. Electronic address: ryan.tomlinson@jefferson.edu.
Drexel University · US

Funding

NGF-TrkA Signaling in Load-Induced Bone FormationR01AR074953 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI TOMLINSON, RYAN · 2019 to 2023
$1.7M
NGF-TrkA Signaling in Dental Implant Osseointegration and OsseoperceptionR03DE028397 · NIDCR · THOMAS JEFFERSON UNIVERSITY · PI TOMLINSON, RYAN · 2019 to 2020
$312k
NIAMS NIH HHS R01 AR074953NIDCR NIH HHS R03 DE028397
6 · The paper itself

Abstract

The periosteal and endosteal surfaces of mature bone are densely innervated by sensory nerves expressing TrkA, the high-affinity receptor for nerve growth factor (NGF). In previous work, we demonstrated that administration of exogenous NGF significantly increased load-induced bone formation through the activation of Wnt signaling. However, the translational potential of NGF is limited by the induction of substantial mechanical and thermal hyperalgesia in mice and humans. Here, we tested the effect of gambogic amide (GA), a recently identified robust small molecule agonist for TrkA, on hyperalgesia and load-induced bone formation. Behavioral analysis was used to assess pain up to one week after axial forelimb compression. Contrary to our expectations, GA treatment was not associated with diminished use of the loaded forelimb or sensitivity to thermal stimulus. Furthermore, dynamic histomorphometry revealed a significant increase in relative periosteal bone formation rate as compared to vehicle treatment. Additionally, we found that GA treatment was associated with an increase in the number of osteoblasts per bone surface in loaded limbs as well as a significant increase in the fold change of Ngf, Wnt7b, and Axin2 mRNA expression as compared to vehicle (control). To test the effect of GA on osteoblasts directly, we cultured MC3T3-E1 cells for up to 21 days in osteogenic differentiation media containing NGF, GA, or vehicle (control). Media containing GA induced the significant upregulation of the osteoblastic differentiation markers Runx2, Bglap2, and Sp7 in a dose-dependent manner, whereas treatment with NGF was not associated with any significant increases in these markers. Furthermore, consistent with our in vivo findings, we observed that administration of 50 nM of GA upregulated expression of Ngf at both Day 3 and Day 7. However, cells treated with the highest dose of GA (500 nM) had significantly increased apoptosis and impaired cell proliferation. In conclusion, our study indicates GA may be useful for augmenting skeletal adaptation to mechanical forces without inducing hyperalgesia.

Indexed as

Receptor, trkAXanthonesAnimalsMiceOsteoblastsOsteogenesisgambogic amideReceptor, trkAXanthonesGambogic amideMechanical loadingNerve growth factorNeurotrophic tyrosine kinase receptor type 1Sensory nerves

Identifiers

PMID33713848
PMCPMC8097708
OpenAlexW3138906047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.